HomeALT • NASDAQ
Altimmune Inc
add
$5.55
5.51%
After Hours:(0.36%)+0.020
$5.57
Closed: Mar 12, 6:31:33 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 5.00K | -86.49% |
Operating expense | 5.09M | 17.50% |
Net income | -23.18M | 26.74% |
Net profit margin | -463.60K | -442.12% |
Earnings per share | -0.33 | -0.33% |
EBITDA | -24.83M | -17.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 131.89M | -33.33% |
Total assets | 139.31M | -33.87% |
Total liabilities | 15.80M | -4.49% |
Total equity | 123.51M | — |
Shares outstanding | 77.01M | — |
Price to book | 3.08 | — |
Return on assets | -43.29% | — |
Return on capital | -47.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -23.18M | 26.74% |
Cash from operations | -18.27M | -10.48% |
Cash from investing | 13.63M | 271.28% |
Cash from financing | 10.09M | -86.14% |
Net change in cash | 5.45M | -88.70% |
Free cash flow | -9.27M | 7.58% |
Previous close
$5.26
Day range
$5.39 - $5.61
Year range
$5.15 - $11.50
Market cap
394.74M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
59